Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial

Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for NCT02395627 is displayed with details of its breast cancer treatment study, including its terminated status, study design, eligibility criteria, and measured outcomes. Study documents and record history are also available.
    Difference
    63%
    Check dated 2026-11-07T13:07:25.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:34:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates and FAQs about the transition from the term “Artificial Intelligence” to “Super Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T16:17:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:07:34.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer now identifies the revision as v3.7.1 instead of v3.7.0. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:05:02.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows Revision: v3.7.0, indicating a site revision, and several older documents/metadata entries were removed from the study listing, reflecting housekeeping updates to the record.
    Difference
    21%
    Check dated 2026-09-19T18:21:37.000Z thumbnail image

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.